# Nantong Chanyoo Pharmatech Co., Ltd. – FDA Inspection, Mar 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/nantong-chanyoo-pharmatech-co-ltd/78df698f-33c9-4ebf-a1bc-bd115f1499f2
Source feed: FDA_Inspections

> FDA inspection 1088295 of Nantong Chanyoo Pharmatech Co., Ltd., March 22, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088295
- Company Name: Nantong Chanyoo Pharmatech Co., Ltd.
- Inspection Date: 2019-03-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1272404 - 2025-05-16](https://www.keypedia.com/records/fda_inspections/nantong-chanyoo-pharmatech-co-ltd/53ed92fb-82be-4c4e-b78b-03b1fd8e08ac)
- FDA Inspection 953681 - 2015-09-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/michele-perry-williams/80741e95-8df3-41c9-b9b8-499fcb97921d)

Company: https://www.keypedia.com/companies/nantong-chanyoo-pharmatech-co-ltd/ccfeb4b8-1b9a-4c2c-a01f-f1afcf289155

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
